148 related articles for article (PubMed ID: 8690754)
1. Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas.
Saegusa M; Takano Y; Kamata Y; Okayasu J
J Cancer Res Clin Oncol; 1996; 122(7):427-32. PubMed ID: 8690754
[TBL] [Abstract][Full Text] [Related]
2. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findings.
Saegusa M; Okayasu I
J Cancer Res Clin Oncol; 1997; 123(8):429-34. PubMed ID: 9292705
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of heterozygosity at the deleted in colorectal carcinoma gene locus and its association with histologic phenotypes in breast carcinoma.
Kashiwaba M; Tamura G; Ishida M
Virchows Arch; 1995; 426(5):441-6. PubMed ID: 7633654
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas.
Ayhan A; Yasui W; Yokozaki H; Seto M; Ueda R; Tahara E
Jpn J Cancer Res; 1994 Jun; 85(6):584-91. PubMed ID: 8063611
[TBL] [Abstract][Full Text] [Related]
6. [A study of loss of heterozygosity and mRNA expression at DCC locus in gastric cancers].
Wang D; Fang D; Luo Y
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):331-4. PubMed ID: 9387268
[TBL] [Abstract][Full Text] [Related]
7. Protein expression of p53 and Bcl-2 has a strong correlation with radiation resistance of laryngeal squamous cell carcinoma but does not predict the radiation failure before treatment.
Ogawa T; Shiga K; Tateda M; Saijo S; Suzuki T; Sasano H; Miyagi T; Kobayashi T
Oncol Rep; 2003; 10(5):1461-6. PubMed ID: 12883724
[TBL] [Abstract][Full Text] [Related]
8. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma.
Maesawa C; Tamura G; Suzuki Y; Ogasawara S; Sakata K; Kashiwaba M; Satodate R
J Pathol; 1995 Jul; 176(3):249-58. PubMed ID: 7674088
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction.
Cho JH; Noguchi M; Ochiai A; Hirohashi S
Lab Invest; 1996 Apr; 74(4):835-41. PubMed ID: 8606493
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S
Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722
[TBL] [Abstract][Full Text] [Related]
12. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
Brewster SF; Browne S; Brown KW
J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
[TBL] [Abstract][Full Text] [Related]
13. Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer.
Graziano F; Cascinu S; Staccioli MP; Catalano V; Rossi MC; Baldelli AM; Giordani P; Muretto P; Catalano G
BMC Cancer; 2001; 1():9. PubMed ID: 11518545
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
15. Fez1/lzts1 alterations in gastric carcinoma.
Vecchione A; Ishii H; Shiao YH; Trapasso F; Rugge M; Tamburrino JF; Murakumo Y; Alder H; Croce CM; Baffa R
Clin Cancer Res; 2001 Jun; 7(6):1546-52. PubMed ID: 11410489
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.
Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
Jpn J Cancer Res; 1996 Nov; 87(11):1153-9. PubMed ID: 9045944
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection.
Wu MS; Shun CT; Wang HP; Sheu JC; Lee WJ; Wang TH; Lin JT
Gastroenterology; 1997 May; 112(5):1457-65. PubMed ID: 9136822
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at the DCC gene locus is not crucial for the acquisition of metastatic potential in oesophageal squamous cell carcinoma.
Maesawa C; Tamura G; Ogasawara S; Suzuki Y; Sakata K; Sugimura J; Nishizuka S; Sato N; Ishida K; Saito K; Satodate R
Eur J Cancer; 1996 May; 32A(5):896-8. PubMed ID: 9081374
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential.
Iino H; Fukayama M; Maeda Y; Koike M; Mori T; Takahashi T; Kikuchi-Yanoshita R; Miyaki M; Mizuno S; Watanabe S
Cancer; 1994 Mar; 73(5):1324-31. PubMed ID: 7906606
[TBL] [Abstract][Full Text] [Related]
20. Aberration of p53 and DCC in gastric and colorectal cancer.
Kataoka M; Okabayashi T; Johira H; Nakatani S; Nakashima A; Takeda A; Nishizaki M; Orita K; Tanaka N
Oncol Rep; 2000; 7(1):99-103. PubMed ID: 10601600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
